期刊文献+

肾功能不全与心肌无复流关系的研究进展 被引量:2

Research Progress of Relationship between Renal Insufficiency and Myocardial No-Reflow
下载PDF
导出
摘要 经皮冠状动脉介入(PCI)是治疗急性心肌梗死(AMI)的主要措施,但是即使成功开通心外膜冠状动脉阻塞血管也并不意味着心肌组织恢复真正有效的灌注。心肌无复流(MNR)是PCI后严重并发症,是AMI患者心脏不良心血管事件的独立预测因子,其出现提示患者临床预后不佳。目前MNR的发生机制尚不清楚,炎症、氧化应激反应在其发生过程中发挥重要作用。在AMI患者中,合并肾功能不全(RI)者心肌血流灌注明显减少,因此RI可能是MNR的独立危险因子之一。 Percutaneous coronary intervention(PCI) is one of the most effective methods to treat patients with acute myocardial infarction. However the successful opening of the epieardial coronary artery occlusion does not mean effective perfusion of myocardial tissue. Myocardial no-reflow (MNR) is one of the worst eomplieations of reperfusion, which is an independentpredietor of cardiac events in AMI patients. Currently,the pathogenesis of MNR has not been fully understood, but inflammation reaction and oxidative stress play important roles in the MNR. Myocardial blood flow perfusion is reduced in patients with renal insufllcieney(Rl) ,so RI may be an independent risk factor for MNR.
出处 《医学综述》 2017年第16期3245-3249,共5页 Medical Recapitulate
关键词 肾功能不全 心肌无复流 炎症反应 氧化应激反应 Renal insufficiency Myocardial no-reflow Inflammation reaction Oxidative stress
  • 相关文献

参考文献2

二级参考文献24

  • 1Parfrey PS,Foley RN,Harnett JD,et al.Outcome and risk factors of ischemic heart disease in chronic uremia[J].Kidney Int,1996,49:1428-1434.
  • 2Locatelli F,Canaud B,Eckardt KU,et al.Oxidative stress in end-stage renal disease:an emerging threat to patient outcome[J].Nephrol Dial Transplant,2003,18:1272-1280.
  • 3National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].AmJ Kidney Dis,2002,39(2,suppl 1):1-266.
  • 4Witko-Sarsat V,Friedlander M,Nguyen-Khoa T,et al.Advanced oxidation protein products as novel mediator of inflammation and monocyte activation in chronic renal failure[J].Immunol,1998,161(5):2524-2532.
  • 5Jonathan H,Peter ST.Alp I,et al.The elephant in uremia:Oxidant stress as a unifying concept of cardiovascular disease in uremia[J].Kidney Int,2002,62:1524-1538.
  • 6Witko-Sarsat V,Friedlander M,Capeillère-Blandin C,et al.Advanced oxidation protein products as a novel marker of oxidative stress in uremia[J].Kidney Int,1996,49(5):1304-1313.
  • 7Mimi--Oka J,Simi T,Djukanovi L,et al.Alteration in plasma antioxidant capacity in various degrees of chronic renal failure[J].Clin Nephrol,1999,51(4):233-241.
  • 8Muntner P, He J,Hamm L, et al. Renal insufficiency andsubsequent death resulting from cardiovascular disease in theUnited States. J Am Soc Nephrol, 2002, 13: 745-753.
  • 9Marenzi G,Moltrasio M, Assanelli E, et al. Impact of cardiacand renal dysfunction on inhospital morbidity and mortality ofpatients with acute myocardial infarction undergoing primaryangioplasty. Am Heart J, 2007,153 :755-762.
  • 10Kim JY, Jeong MH, Ahn YK, et al. Decreased GlomerularFiltration Rate is an Independent Predictor of In-HospitalMortality in Patients With ST-Segment Elevation MyocardialInfarction Undergoing Primary Percutaneous CoronaryIntervention. Korean Circ J, 2011,41 : 184-190.

共引文献14

同被引文献23

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部